Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-31

Clinical Trial Update: Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty [Phase 1]

View source ↗

Summary

Phase 1 trial characterizing pharmacokinetics, relative bioavailability, and safety of INL-001 versus Marcaine in open hernioplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INL-001
  • Marcaine (bupivacaine)

Snippet

Sponsor: Innocoll | Conditions: Hernioplasty | Phase 1 | Status: COMPLETED | Results posted: 2020-12-31